Top Purchase Related
Home
>
Node
>
Subnode

Therapy of breast cancer

Kolb, R.

Wiener Klinische Wochenschrift 96(13): 485-486

1984

ISSN/ISBN: 0043-5325
PMID: 6475077
Document Number: 234672

Document emailed within 1 workday
Secure & encrypted payments

Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Rosenberg, L.; Palmer, J.R.; Shapiro, S. 1992: Oestrogen replacement therapy and breast cancer Results from the Slone Epidemiology Units Toronto Breast Cancer Study Mann, R D Hormone replacement therapy and breast cancer risk : 253-264
Castiglione-Gertsch, M.; Tattersall, M.; Hacking, A.; Goldhirsch, A.; Gudgeon, A.; Gelber, R.D.; Lindtner, J.; Coates, A.; Collins, J.; Isley, M.; Senn, H.J.; Rudenstam, C.M. 1997: Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group European Journal of Cancer 33(14): 2321-2325
Hooning, M.J.; van Dongen, J.A.; Went, G. 1991: Changing indications for breast conserving therapy: proportion of patients with operable breast cancer suitable for breast conservation Netherlands Journal of Surgery 43(4): 102-104
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Ohsumi, S.; Takashima, S.; Saeki, T.; Aogi, K. 2002: Breast-conserving therapy consisting of wide excision, axillary dissection, and radiotherapy for early-stage breast cancer: the experience of the National Shikoku Cancer Center Biomedicine and PharmacoTherapy 56(Suppl): 196s-200s
Tominaga, T.; Abe, O.; Izuo, M.; Isono, K.; Enomoto, K.; Nishi, M.; Fukami, A.; Muto, T.; Morioka, Y.; Watanabe, H. 1993: Correlations between estrogen receptor and prognostic factors of patients with breast cancer. the Kanto Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(14): 2171-2176
Mitsuyama, S.; Kuroda, Y.; Ohsato, K.; Nakamura, Y.; Murakami, F.; Nishikata, F.; Ikeda, S.; Egami, T.; Mori, A.; Ohe, H. 1996: Administration method and recurrence-preventing effect of medroxyprogesterone acetate (MPA) as a postoperative adjuvant endocrine therapy for stage III breast cancer. Kitakyushu Collaborative Study Group for Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(9): 1153-1160
Friedrich, M. 2000: Vitamin D and breast cancer: new approaches for hormonal therapy of breast cancer Clinical and Experimental Obstetrics and Gynecology 27(2): 77-82
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Tangkaratt, S. 2004: Mammographic findings in breast cancer patients, who were treated with breast conserving therapy Journal of the Medical Association of Thailand 87(12): 1439-1443
Seewald, D.H.; Zoidl, J.P.; Track, C.; Putz, E.; Hammer, J. 1994: Quality assurance of interstitial irradiation in the breast-conserving therapy of breast cancer Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 170(3): 147-150
Lüscher, N.J. 1992: Reconstructive measures in local recurrence after breast saving therapy of breast cancer Helvetica Chirurgica Acta 59(1): 181-187
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Mannell, A. 2005: Breast-conserving therapy in breast cancer patients--a 12-year experience South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie 43(2): 28-30; Discussion 30, 32
Von Fournier, D.; Wannenmacher, M.; Hirsch, J. 1992: Josef Hirsch--pioneer of breast saving therapy of breast cancer Zentralblatt für Gynakologie 114(4): 201-203
Stierli, P.; Spichtig, S.; Aeberhard, P. 1992: Breast saving therapy of breast cancer: sensitivity of mammography in relation to primary tumor size Helvetica Chirurgica Acta 59(1): 247-252
Semiglazov, V.F.; Semiglazov, V.V.; Petrenko, O.L.; Komyakhov, A.V.; Dashyan, G.A.; Paltuev, R.M.; Semiglazova, T.Y.; Manikhas, A.G.; Bozhok, A.A.; Lalak, I.A. 2015: Breast-Conserving Surgery after Neoadjuvant Therapy for Breast Cancer Voprosy Onkologii 61(3): 381-386
Lüscher, N.J.; Tschopp, H.M. 1989: Local late sequelae following breast saving therapy of breast cancer: problem cases and possibilities for their correction Helvetica Chirurgica Acta 55(6): 861-868
Morris, A.D.; Morris, R.D.; Wilson, J.F.; White, J.; Steinberg, S.; Okunieff, P.; Arriagada, R.; Lê, M.G.; Blichert-Toft, M.; van Dongen, J.A. 1997: Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival Cancer Journal from Scientific American 3(1): 6-12